Search - tctmd.com

Displaying 81 - 100 of 117

Sort: Relevancy | Date

News Daily News

Un Comité Asesor de la FDA No Avala la Afirmación de que Ezetimibe Reduce los Episodios CV

Michael O'Riordan

December 15, 2015

News Daily News

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

Michael O'Riordan

December 15, 2015

Presentation TCT 2015

I Believe That Most PCI Procedures for Stable CAD Are NOT Worth the Time/Effort/Risk/Money!

Presenter: Eric R. Bates, Spencer B. King III, Sanjay Kaul

October 13, 2015

News Conference News TCT 2015

Discussion Highlights Merits, Limitations of Small Trials

Yael L. Maxwell

October 13, 2015

Presentation TCT 2015

Keynote Lecture 3: Single-Center vs Multicenter Trials Pros, Cons, and Integration Into Evidence

Presenter: Ajay J. Kirtane, Roxana Mehran, Sanjay Kaul

October 12, 2015

Presentation TCT 2015

The 10 Most Common Statistical Mistakes and Misinterpretations I See Again and Again

Presenter: Robert A. Harrington, Pascal Vranckx, Sanjay Kaul

October 11, 2015

Presentation TCT 2015

Bayesian Statistics: Can They Be Trusted (or Understood)?!

Presenter: Stuart J. Pocock, Jan Tijssen, Sanjay Kaul

October 11, 2015

News Daily News

患者级的集合分析表明，可以在直接PCI中使用比伐卢定

Yael L. Maxwell

January 12, 2015

News Daily News

Un Análisis Conjunto a Nivel del Paciente Avala el Uso de Bivalirudina en PCI Primarias

Yael L. Maxwell

January 12, 2015

News Daily News

Patient-Level Pooled Analysis Supports Bivalirudin Use in Primary PCI

Yael L. Maxwell

January 12, 2015

News Daily News

基于导管的斑块脂质测量可预测未来事件

December 10, 2014

News Daily News

Las Mediciones mediante Catéter de los Lípidos de la Placa predicen Episodios Futuros

December 10, 2014

News Daily News

Catheter-Based Measurement of Plaque Lipid Predicts Future Events

December 10, 2014

Presentation TCT 2014

Reflections on Incorporating Vorapaxar in Contemporary Practice: Who Are the Right Patients?

Presenter: Ori Ben-Yehuda, Matthew T. Roe, David J. Moliterno, Sanjay Kaul

September 15, 2014

News Conference News TCT 2014

PFO Closure for Stroke: A Call to Revise the Guidelines

September 14, 2014

Presentation TCT 2014

The Clinical Trialists Perspective on the Evidence and Certainty: How Should It Influence Regulatory Decisions, Clinical Practice, and Guidelines?

Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, Sanjay Kaul

September 13, 2014

Presentation TCT 2014

No: And Ill Show You Why!

Presenter: Sanjay Kaul, Ajay J. Kirtane, Joanna J. Wykrzykowska

September 13, 2014

Presentation TCT 2014

Yes: What is WORST is BEST!

Presenter: Sanjay Kaul, Ajay J. Kirtane, Christopher B. Granger

September 13, 2014

Presentation TCT 2014

Affirmative: Time to Move On!

Presenter: Sanjay Kaul, Ajay J. Kirtane, Sripal Bangalore

September 13, 2014

Presentation TCT 2014

Negatory: There are Logical Reasons for Why Renal Artery Denervation Failed in SIMPLICITY HTN-3!

Presenter: Sanjay Kaul, Ajay J. Kirtane, David E. Kandzari

September 13, 2014

Advertisement

Un Comité Asesor de la FDA No Avala la Afirmación de que Ezetimibe Reduce los Episodios CV

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

I Believe That Most PCI Procedures for Stable CAD Are NOT Worth the Time/Effort/Risk/Money!

Discussion Highlights Merits, Limitations of Small Trials

Keynote Lecture 3: Single-Center vs Multicenter Trials Pros, Cons, and Integration Into Evidence

The 10 Most Common Statistical Mistakes and Misinterpretations I See Again and Again

Bayesian Statistics: Can They Be Trusted (or Understood)?!

患者级的集合分析表明，可以在直接PCI中使用比伐卢定

Un Análisis Conjunto a Nivel del Paciente Avala el Uso de Bivalirudina en PCI Primarias

Patient-Level Pooled Analysis Supports Bivalirudin Use in Primary PCI

基于导管的斑块脂质测量可预测未来事件

Las Mediciones mediante Catéter de los Lípidos de la Placa predicen Episodios Futuros

Catheter-Based Measurement of Plaque Lipid Predicts Future Events

Reflections on Incorporating Vorapaxar in Contemporary Practice: Who Are the Right Patients?

PFO Closure for Stroke: A Call to Revise the Guidelines

The Clinical Trialists Perspective on the Evidence and Certainty: How Should It Influence Regulatory Decisions, Clinical Practice, and Guidelines?

No: And Ill Show You Why!

Yes: What is WORST is BEST!

Affirmative: Time to Move On!

Negatory: There are Logical Reasons for Why Renal Artery Denervation Failed in SIMPLICITY HTN-3!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content